Header Logo

Connection

SUSAN HILSENBECK to Prostatic Neoplasms, Castration-Resistant

Back to Details
This is a "connection" page, showing publications SUSAN HILSENBECK has written about Prostatic Neoplasms, Castration-Resistant.
SUSAN HILSENBECK
Connection Strength
0.216
Prostatic Neoplasms, Castration-Resistant
  1. Real-world effectiveness of darolutamide in metastatic castration-resistant prostate cancer. Endocr Relat Cancer. 2025 Jun 01; 32(6).
    View in: PubMed
    Score: 0.216
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.